Metformin or rapamycin supplementation increased LVEF and LVFS, decreased HW/BW ratios and ameliorated hypertrophic features and myocardial fibrosis in WT and Bmi‐1–/– mice with Ang II treatment (Figure 3). Here, BMI1 is linked to Myocardial fibrosis.